Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
35 studies found for:    Open Studies | "Pruritus"
Show Display Options
Rank Status Study
21 Recruiting Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury
Conditions: Burn Injury;   Chronic Pain;   Pruritus;   Itching
Intervention: Device: Transcranial direct current stimulation (tDCS)
22 Recruiting Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients
Condition: Moderate to Severe Plaque Psoriasis
Intervention: Drug: Apremilast;Apremilast;Apremilast 10 MG; 20 MG; 30 MG Oral Tablet
23 Recruiting The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial
Conditions: Itchiness;   Hypertrophic Scar;   Botulinum Toxin
Interventions: Drug: Botulinum Toxins;   Drug: Placebo
24 Recruiting Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration
Conditions: Fractures, Bone;   Nausea and Vomiting, Postoperative;   Pruritus;   Morphine Adverse Reaction;   Satisfaction, Personal
Interventions: Drug: Dexamethasone;   Drug: Ondansetron;   Other: Saline
25 Not yet recruiting Dose-ranging Study of Nemolizumab in Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Nemolizumab;   Drug: Placebo
26 Recruiting Bleach Bath Treatment of Adults With Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention: Drug: bleach bath (sodium hypochlorite)
27 Recruiting Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
Condition: Conjunctivitis, Allergic
Intervention: Drug: Alcaftadine Ophthalmic Solution 0.25%
28 Recruiting Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Secukinumab 150 mg s.c.;   Drug: Secukinumab 300 mg s.c.;   Drug: Placebo
29 Recruiting Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot
Condition: Tinea Pedis
Interventions: Drug: Nitric Oxide;   Drug: Water
30 Recruiting A Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: INCB018424 cream;   Drug: Triamcinolone 0.1% cream;   Drug: Vehicle cream
31 Not yet recruiting Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Dermal Neurofibroma
Conditions: Appearance Distress;   Bothered by Itching Skin;   Cafe Au Lait Spot;   Cutaneous Neurofibroma;   Disfigurement;   Dysplasia;   Lisch Nodule;   Neurofibromatosis Type 1;   NF1 Gene Mutation;   Optic Nerve Glioma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Selumetinib
32 Recruiting Three-Arm Trial of Novel Treatment for Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: Experimental Drug SESC 01;   Drug: Placebo;   Drug: Terbinafine Hydrochloride
33 Recruiting Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis
Condition: Foot Infection Tinea Pedis
Interventions: Drug: infected group;   Drug: control group
34 Recruiting Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
Condition: Arthritis, Psoriatic
Intervention: Drug: Tofacitinib
35 Not yet recruiting A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp
Condition: Psoriasis
Interventions: Drug: Apremilast;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Study has passed its completion date and status has not been verified in more than two years.